Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Olivia Newton-John Cancer Research Institute
Imperial College London
Ohio State University Comprehensive Cancer Center
University of Alberta
Crinetics Pharmaceuticals Inc.
Amgen
Merck Sharp & Dohme LLC
University of California, San Francisco
Orano Med LLC
Instituto do Cancer do Estado de São Paulo
Melanoma and Skin Cancer Trials Limited
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
CHU de Quebec-Universite Laval
University Medical Center Goettingen